Molecular Health
We are dedicated to building software solutions that transform biomedical data into actionable insights.
We are dedicated to building software solutions that transform biomedical data into actionable insights.
Molecular Health is a Germany-based startup founded in 2004, with a focus on pioneering precision in healthcare through cloud-based data analytics. The company's slogan emphasizes its commitment to leveraging big data to improve patient outcomes and advanced drug development. Molecular Health's flagship product, the Dataome® technology platform, analyzes molecular and clinical data of individual patients against global medical, biological, and pharmacological knowledge. This enables more accurate diagnostic, therapeutic, and drug safety decisions, impacting patient treatment and effective drug development. Notably, the company received a €25.00MPrivate Equity Round investment on 16 November 2015 from Dievini Hopp Biotech Holding, an investment vehicle of former SAP CEO and founder Dietmar Hopp. This funding supports Molecular Health's efforts to drive innovation and precision in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | €25.00M | 1 |
|
16 Nov 2015 |
No recent news or press coverage available for Molecular Health.
We care about your data, and we'd love to use cookies make your experience better.
